SNPS News

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Synopsys Investors Have Opportunity to Lead Class Action Lawsuit

SNPS FRAUD UPDATE: Important Synopsys, Inc. Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 30

Synopsys Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Synopsys, Inc. - SNPS

Levi & Korsinsky Reminds Synopsys, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 30, 2025 – SNPS

SNPS COURT ALERT: Synopsys, Inc. Securities Fraud Class Action is Ongoing - Investors with Losses Alerted to Contact BFA Law by December 30

Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf

SNPS DEADLINE: Faruqi & Faruqi Reminds Synopsys Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 30, 2025 - SNPS

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 30, 2025 in Synopsys, Inc. Lawsuit - SNPS

SYNOPSYS NOTICE: Synopsys, Inc. (SNPS) Investors are Notified of Securities Fraud Class Action and to Contact BFA Law by December 30

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against MoonLake Immunotherapeutics (MLTX), DexCom, Inc. (DXCM), and Synopsys, Inc. (SNPS)